The global immunoassay market is growing at significant rate, due to mounting occurrence of chronic and infectious diseases and technological improvement in the instruments.

The market has witnessed high demand for kits and reagents over the last few years due to mounting number of immunoassay tests and mounting occurrence of chronic and infectious diseases.

Request for sample copy of this research report at: https://www.vynzresearch.com/healthcare/immunoassay-market/request-sample

The technological progressions in immunoassay instruments, essential function of immunoassays in drug and alcohol analysis, boosting acceptance of immunoassay-based point-of-care testing and speedy testing and progression in the biotechnology and biopharmaceutical industries are the primary growth drivers for immunoassay market.

North America is the largest immunoasay market as in the region the prevalence of chronic disease and infectious diseases is increasing.

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base.

Key players in the immunoassay market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe.

Roche, Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, Siemens, QIAGEN, Danaher, Ortho Clinical Diagnostics, Sysmex, Bio-Rad Laboratories, BioMérieux, Becton, Dickinson & Company, and Mindray are the key players offering immunoassay.

Source: VynZ Research